365 related articles for article (PubMed ID: 28708432)
21. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.
Sheng X; Guo Y; Lu Y
Medicine (Baltimore); 2017 Jul; 96(28):e7476. PubMed ID: 28700487
[TBL] [Abstract][Full Text] [Related]
22. CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis.
Vasilatos SN; Broadwater G; Barry WT; Baker JC; Lem S; Dietze EC; Bean GR; Bryson AD; Pilie PG; Goldenberg V; Skaar D; Paisie C; Torres-Hernandez A; Grant TL; Wilke LG; Ibarra-Drendall C; Ostrander JH; D'Amato NC; Zalles C; Jirtle R; Weaver VM; Seewaldt VL
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):901-14. PubMed ID: 19258476
[TBL] [Abstract][Full Text] [Related]
23. Differential
Gardini ES; Chen GG; Fiacco S; Mernone L; Willi J; Turecki G; Ehlert U
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455834
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
25. p53 Binds to estrogen receptor 1 promoter in human breast cancer cells.
Rasti M; Arabsolghar R; Khatooni Z; Mostafavi-Pour Z
Pathol Oncol Res; 2012 Apr; 18(2):169-75. PubMed ID: 21655924
[TBL] [Abstract][Full Text] [Related]
26. The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer.
Pirouzpanah S; Taleban FA; Atri M; Abadi AR; Mehdipour P
Cancer Causes Control; 2010 Dec; 21(12):2101-11. PubMed ID: 20711807
[TBL] [Abstract][Full Text] [Related]
27. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
28. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
[TBL] [Abstract][Full Text] [Related]
29. Genetic and epigenetic modifications of adiponectin gene: Potential association with breast cancer risk.
Pasha HF; Mohamed RH; Toam MM; Yehia AM
J Gene Med; 2019 Oct; 21(10):e3120. PubMed ID: 31415715
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
31. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
[TBL] [Abstract][Full Text] [Related]
32. ESR1 and PGR gene promoter methylation and correlations with estrogen and progesterone receptors in ductal and lobular breast cancer.
Medina-Jaime AD; Reyes-Vargas F; Martinez-Gaytan V; Zambrano-Galvan G; Portillo-Delcampo E; Burciaga-Nava JA; Reyes-Romero M; Sifuentes-Alvarez A
Asian Pac J Cancer Prev; 2014; 15(7):3041-4. PubMed ID: 24815444
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer family history and allele-specific DNA methylation in the legacy girls study.
Wu HC; Do C; Andrulis IL; John EM; Daly MB; Buys SS; Chung WK; Knight JA; Bradbury AR; Keegan THM; Schwartz L; Krupska I; Miller RL; Santella RM; Tycko B; Terry MB
Epigenetics; 2018; 13(3):240-250. PubMed ID: 29436922
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor alpha (ERα) promoter methylation status in tumor and serum DNA in Egyptian breast cancer patients.
Hagrass HA; Pasha HF; Ali AM
Gene; 2014 Nov; 552(1):81-6. PubMed ID: 25218234
[TBL] [Abstract][Full Text] [Related]
35. DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility.
Ambatipudi S; Horvath S; Perrier F; Cuenin C; Hernandez-Vargas H; Le Calvez-Kelm F; Durand G; Byrnes G; Ferrari P; Bouaoun L; Sklias A; Chajes V; Overvad K; Severi G; Baglietto L; Clavel-Chapelon F; Kaaks R; Barrdahl M; Boeing H; Trichopoulou A; Lagiou P; Naska A; Masala G; Agnoli C; Polidoro S; Tumino R; Panico S; Dollé M; Peeters PHM; Onland-Moret NC; Sandanger TM; Nøst TH; Weiderpass E; Quirós JR; Agudo A; Rodriguez-Barranco M; Huerta Castaño JM; Barricarte A; Fernández AM; Travis RC; Vineis P; Muller DC; Riboli E; Gunter M; Romieu I; Herceg Z
Eur J Cancer; 2017 Apr; 75():299-307. PubMed ID: 28259012
[TBL] [Abstract][Full Text] [Related]
36. Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.
Zhao L; Wang L; Jin F; Ma W; Ren J; Wen X; He M; Sun M; Tang H; Wei M
Breast Cancer Res Treat; 2009 Sep; 117(2):253-9. PubMed ID: 18814026
[TBL] [Abstract][Full Text] [Related]
37. Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity.
McCullough LE; Chen J; White AJ; Xu X; Cho YH; Bradshaw PT; Eng SM; Teitelbaum SL; Terry MB; Garbowski G; Neugut AI; Hibshoosh H; Santella RM; Gammon MD
Int J Cancer Clin Res; 2015; 2(1):. PubMed ID: 26005715
[TBL] [Abstract][Full Text] [Related]
38.
Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Politaki E; Voutsina A; Psyrri A; Georgoulias V; Lianidou E
Clin Cancer Res; 2018 Mar; 24(6):1500-1510. PubMed ID: 29284708
[No Abstract] [Full Text] [Related]
39. Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: Effects of aging, body mass index and breast cancer incidence.
Gomes-Rochette NF; Souza LS; Tommasi BO; Pedrosa DF; Eis SR; Fin ID; Vieira FL; Graceli JB; Rangel LB; Silva IV
PLoS One; 2017; 12(2):e0169266. PubMed ID: 28199328
[TBL] [Abstract][Full Text] [Related]
40. ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases.
Kirn V; Strake L; Thangarajah F; Richters L; Eischeid H; Koitzsch U; Odenthal M; Fries J
Clin Exp Metastasis; 2018 Oct; 35(7):707-712. PubMed ID: 30173322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
